Skip to main content

Table 1 Clinical characteristics of patients

From: Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris

Characteristics

Control (n = 40)

SAP (n = 60)

UAP (n = 60)

AMI (n = 60)

Age (years)

62.6 ± 7.9

61.9 ± 9.9

60.6 ± 9.9

62.9 ± 10.3

Sex (male/female)

29/11

44/16

37/23

41/19

Hypertension, n (%)

22 (55)

34 (58)

38 (61.3)

32 (61.2)

Diabetes, n (%)

6 (15)

20 (28)

14 (38.7)

20 (37.3)

Smoking, n (%)

14 (35)

26 (40)

23 (48)

28 (35.8)

BMI (Kg/m2)

23. 2 ± 3.9

24.8 ± 3.0*

25.8 ± 2.7*

25.9 ± 2.6*

TC (mmol/L)

4.52 ± 0.99

4.09 ± 0.95

4.53 ± 1.19

4.40 ± 0.86

TG (mmol/L)

1.68 ± 1.75

1.84 ± 1.04

1.94 ± 1.61

1.82 ± 1.42

LDL-C (mmol/L)

2.71 ± 0.87

2.38 ± 0.81

2.69 ± 1.16

2.71 ± 0.78

HDL-C (mmol/L)

1.20 ± 0.34

1.11 ± 0.41

1.09 ± 0.37

0.94 ± 0.26*

GLU (mmol/L)

5.07 ± 0.9

5.67 ± 2.03

6.22 ± 2.67

6.78 ± 2.91*

Creatinine (μmol/L)

76.28 ± 14.97

88.24 ± 23.03*

82.51 ± 20.29*

87.77 ± 35.23*

CRP (mg/L)

1.49 ± 0.99

2.61 ± 4.04

4.14 ± 4.09*

7.53 ± 7.08*

LVEF (%)

65.7 ± 5.0

62.6 ± 8.5

56.9 ± 12.5*

48.5 ± 10.4*

LVEDD (mm)

46.7 ± 3.2

48.1 ± 3.7

51.5 ± 7.6*

52.7 ± 5.5*

Gensini score

0

44.0 ± 30.2*

52.0 ± 28.4*

61.9 ± 34.5*

Medications, n (%)

    

Aspirin

6 (15)

24 (40)

23 (38.3)

25 (41.7)

β-blocker

6 (15)

22 (36.7)

26 (43.3)

30 (50)

ACEI/ARB

10 (25)

22 (36.7)

26 (43.3)

21 (35)

CCB

16 (40)

32 (53.3)

28 (46.7)

26 (43.3)

Statin

9 (22.5)

22 (52)

21 (35)

20 (33.3)

Nitrate

9 (22.5)

9 (15)

16 (26.7)

17 (28.3)

  1. The data are given as the mean ± SD or number of patients. SAP: stable angina pectoris; UAP: unstable angina pectoris; AMI: acute myocardial infarction; TC: total cholesterol; TG: total triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; GLU: fasting glucose; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic dimension; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: Calcium channel blocker.
  2. *P < 0.05 vs. control.